Cargando…

Extensive undertreatment of osteoporosis in older Swedish women

SUMMARY: In a population-based study of older Swedish women, we investigated the proportion of women treated with osteoporosis medication in relation to the proportion of women eligible for treatment according to national guidelines. We found that only a minority (22%) of those eligible for treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorentzon, M., Nilsson, A. G., Johansson, H., Kanis, J. A., Mellström, D., Sundh, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546648/
https://www.ncbi.nlm.nih.gov/pubmed/30805678
http://dx.doi.org/10.1007/s00198-019-04872-4
_version_ 1783423544737136640
author Lorentzon, M.
Nilsson, A. G.
Johansson, H.
Kanis, J. A.
Mellström, D.
Sundh, D.
author_facet Lorentzon, M.
Nilsson, A. G.
Johansson, H.
Kanis, J. A.
Mellström, D.
Sundh, D.
author_sort Lorentzon, M.
collection PubMed
description SUMMARY: In a population-based study of older Swedish women, we investigated the proportion of women treated with osteoporosis medication in relation to the proportion of women eligible for treatment according to national guidelines. We found that only a minority (22%) of those eligible for treatment were prescribed osteoporosis medication. INTRODUCTION: Fracture rates increase markedly in old age and the incidence of hip fracture in Swedish women is among the highest in the world. Although effective pharmacological treatment is available, treatment rates remain low. Limited data are available regarding treatment rates in relation to fracture risk in a population-based setting in older women. Therefore, we aimed to investigate the proportion of older women eligible for treatment according to Swedish Osteoporosis Society (SvOS) guidelines. METHODS: A population-based study was performed in Gothenburg in 3028 older women (77.8 ± 1.6 years [mean ± SD]). Bone mineral density of the spine and hip was measured with dual-energy X-ray absorptiometry. Clinical risk factors for fracture and data regarding osteoporosis medication was collected with self-administered questionnaires. Logistic regression was used to evaluate whether the 10-year probability of sustaining a major osteoporotic fracture (FRAX-score) or its components predicted treatment with osteoporosis medication. RESULTS: For the 2983 women with complete data, 1107 (37%) women were eligible for treatment using SvOS criteria. The proportion of these women receiving treatment was 21.8%. For women eligible for treatment according to SvOS guidelines, strong predictors for receiving osteoporosis medication were glucocorticoid treatment (odds ratio (95% CI) 2.88 (1.80–4.59)) and prior fracture (2.58 (1.84–3.61)). CONCLUSION: This study demonstrates that a substantial proportion of older Swedish women should be considered for osteoporosis medication given their high fracture risk, but that only a minority receives treatment.
format Online
Article
Text
id pubmed-6546648
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-65466482019-06-19 Extensive undertreatment of osteoporosis in older Swedish women Lorentzon, M. Nilsson, A. G. Johansson, H. Kanis, J. A. Mellström, D. Sundh, D. Osteoporos Int Original Article SUMMARY: In a population-based study of older Swedish women, we investigated the proportion of women treated with osteoporosis medication in relation to the proportion of women eligible for treatment according to national guidelines. We found that only a minority (22%) of those eligible for treatment were prescribed osteoporosis medication. INTRODUCTION: Fracture rates increase markedly in old age and the incidence of hip fracture in Swedish women is among the highest in the world. Although effective pharmacological treatment is available, treatment rates remain low. Limited data are available regarding treatment rates in relation to fracture risk in a population-based setting in older women. Therefore, we aimed to investigate the proportion of older women eligible for treatment according to Swedish Osteoporosis Society (SvOS) guidelines. METHODS: A population-based study was performed in Gothenburg in 3028 older women (77.8 ± 1.6 years [mean ± SD]). Bone mineral density of the spine and hip was measured with dual-energy X-ray absorptiometry. Clinical risk factors for fracture and data regarding osteoporosis medication was collected with self-administered questionnaires. Logistic regression was used to evaluate whether the 10-year probability of sustaining a major osteoporotic fracture (FRAX-score) or its components predicted treatment with osteoporosis medication. RESULTS: For the 2983 women with complete data, 1107 (37%) women were eligible for treatment using SvOS criteria. The proportion of these women receiving treatment was 21.8%. For women eligible for treatment according to SvOS guidelines, strong predictors for receiving osteoporosis medication were glucocorticoid treatment (odds ratio (95% CI) 2.88 (1.80–4.59)) and prior fracture (2.58 (1.84–3.61)). CONCLUSION: This study demonstrates that a substantial proportion of older Swedish women should be considered for osteoporosis medication given their high fracture risk, but that only a minority receives treatment. Springer London 2019-02-25 2019 /pmc/articles/PMC6546648/ /pubmed/30805678 http://dx.doi.org/10.1007/s00198-019-04872-4 Text en © The Author(s) 2019 OpenAccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Lorentzon, M.
Nilsson, A. G.
Johansson, H.
Kanis, J. A.
Mellström, D.
Sundh, D.
Extensive undertreatment of osteoporosis in older Swedish women
title Extensive undertreatment of osteoporosis in older Swedish women
title_full Extensive undertreatment of osteoporosis in older Swedish women
title_fullStr Extensive undertreatment of osteoporosis in older Swedish women
title_full_unstemmed Extensive undertreatment of osteoporosis in older Swedish women
title_short Extensive undertreatment of osteoporosis in older Swedish women
title_sort extensive undertreatment of osteoporosis in older swedish women
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546648/
https://www.ncbi.nlm.nih.gov/pubmed/30805678
http://dx.doi.org/10.1007/s00198-019-04872-4
work_keys_str_mv AT lorentzonm extensiveundertreatmentofosteoporosisinolderswedishwomen
AT nilssonag extensiveundertreatmentofosteoporosisinolderswedishwomen
AT johanssonh extensiveundertreatmentofosteoporosisinolderswedishwomen
AT kanisja extensiveundertreatmentofosteoporosisinolderswedishwomen
AT mellstromd extensiveundertreatmentofosteoporosisinolderswedishwomen
AT sundhd extensiveundertreatmentofosteoporosisinolderswedishwomen